STASKA Pharmaceuticals is an outsourcing facility offering sterile products to a variety of healthcare providers and offices. As the only FDA registered 503B outsourcing facility in Nebraska, STASKA prides itself on transparency, accessibility, and technical expertise. Through the uncompromised quality of its products and services, STASKA is dedicated to enhancing pharmaceutical supply for patients and providers.
Quality Pharmaceutical Products Available Across the US.
Our Leadership
Lyn Leitner, Pharm.D. — CEO
Dr. Lyndon Leitner is the Founder, President, and Chief Executive Officer of STASKA Pharmaceuticals. With more than two decades of experience in pharmacy practice, pharmaceutical operations, and healthcare leadership, Dr. Leitner has dedicated his career to improving patient access to high-quality medications and advancing pharmaceutical compounding standards.
Prior to founding STASKA, Dr. Leitner successfully owned and operated an independent pharmacy for over ten years, where he developed extensive expertise in pharmacy management, patient care, regulatory compliance, and business operations. His experience spans retail pharmacy, healthcare administration, and pharmaceutical manufacturing, providing a unique perspective on the challenges faced by healthcare providers and patients alike.
Under Dr. Leitner’s leadership, STASKA has grown into an FDA-registered outsourcing facility focused on delivering high-quality sterile compounded medications to healthcare providers nationwide. He has led significant investments in quality systems, manufacturing infrastructure, regulatory compliance, and operational excellence, positioning the company for continued growth and long-term success.
Dr. Leitner earned his Doctor of Pharmacy degree from the University of Nebraska Medical Center and remains committed to building a culture centered on quality, integrity, accountability, and patient safety.
Maggy Lawson, Pharm.D. — Quality Director
Maggy Lawson, PharmD, serves as Quality Director at STASKA Pharmaceuticals, where she oversees quality systems, regulatory compliance, and continuous improvement. As both a pharmacist and a quality leader, Dr. Lawson approaches 503B sterile compounding with a clear understanding that quality is not an abstract requirement, but a responsibility that directly affects healthcare providers, patient access, and the people who rely on these medications.
Prior to joining STASKA, Dr. Lawson spent ten years as Pharmacy Manager and Pharmacist-in-Charge for an independent community pharmacy. Her work in patient safety, workflow improvement, and compliance-driven process changes gave her a firsthand understanding of how medication access, provider relationships, practical problem-solving, and trusted pharmacy partnerships directly affect patient care. That experience continues to inform her view that quality systems should support both regulatory expectations and the real-world needs of providers and patients.
At STASKA, Dr. Lawson’s work is focused on strengthening a quality culture built on continual learning, shared accountability, and the continued development of robust quality systems. She recognizes the important role outsourcing facilities play in helping healthcare providers meet patient needs, particularly when access, availability, or clinical circumstances require needed compounded medications. Her focus is on building systems and relationships that support responsible decision-making, reliable operations, and the consistent production of medications that providers and patients can trust.
Nick Shada, CPA — Sales Director
Nick Shada, CPA, serves as Director of Sales for STASKA Pharmaceuticals, where he leads the company’s national sales strategy and business development initiatives. Leveraging his background as a Certified Public Accountant and business professional, Mr. Shada brings a unique financial and strategic perspective to customer relationships, helping healthcare organizations identify solutions that deliver both clinical value and operational efficiency.
With extensive experience in pharmaceutical sales, business development, and account management, Mr. Shada has built a reputation for developing long-term partnerships based on trust, responsiveness, and a thorough understanding of customer needs. He works closely with hospitals, surgery centers, physician practices, and other healthcare providers to deliver high-quality sterile compounded medications backed by exceptional service.
As a member of STASKA’s leadership team, Mr. Shada collaborates with executive leadership, operations, and quality to align commercial strategy with the company’s commitment to regulatory compliance, manufacturing excellence, and patient safety. His combination of financial expertise and pharmaceutical industry experience supports STASKA’s continued growth and reinforces its mission of providing reliable, high-quality compounded medications to healthcare providers nationwide.
Collin Mach — Director of Quality Systems and Compliance
Collin Mach serves as Director of Quality Systems and Compliance for STASKA Pharmaceuticals. He is responsible for overseeing the company’s quality management system, regulatory compliance initiatives, and continuous improvement efforts to ensure STASKA consistently meets the highest standards of pharmaceutical manufacturing and patient safety.
Since joining STASKA, Mr. Mach has played a key role in strengthening the company’s quality infrastructure, leading major quality system enhancements, supporting FDA inspection readiness, and implementing operational improvements across manufacturing and quality operations. He has also been instrumental in the expansion of STASKA’s manufacturing and laboratory capabilities, helping position the company for continued growth while maintaining a strong commitment to cGMP compliance and operational excellence.
Working closely with executive leadership, production, and quality teams, Mr. Mach helps drive strategic initiatives that enhance efficiency, strengthen compliance, and foster a culture of accountability and continuous improvement throughout the organization. Mr. Mach is committed to ensuring that every process, every step, and every decision reflects STASKA’s dedication to quality, integrity, and patient safety.
What Sets Us Apart
Meaningful Innovation
We foster a culture of continuous improvement, transforming ideas into practical solutions that enhance quality, strengthen our processes, and expand access to reliable pharmaceutical products. Through innovation in manufacturing, technology, and customer experience, we continuously improve the way we serve healthcare providers.
High Operational Performance
We combine ISO-classified cleanrooms, advanced analytical laboratories, state-of-the-art equipment, and robust quality systems to deliver consistent manufacturing performance and uncompromising quality. Every step of our process is designed to ensure safety, reliability, efficiency, and regulatory compliance.
Improved Outcomes
We work collaboratively with healthcare providers to deliver reliable pharmaceutical solutions that support better patient care. By focusing on quality, consistency, and service, we help improve outcomes for providers and the patients they serve.
Safety & Transparency
Patient safety and regulatory compliance are the foundation of everything we do. Through rigorous quality systems, comprehensive testing, and open communication, we provide confidence in every product and every partnership.
Time. Cost. Convenience.
We simplify the ordering experience through dependable service, efficient operations, and streamlined processes. From ordering through delivery, we help providers save time, reduce complexity, and maintain a reliable supply of the products they need.
Commitment to Excellence
Excellence is the standard that guides every aspect of our organization. Through accountability, collaboration, continuous improvement, and an unwavering commitment to quality, we strive to exceed expectations and build lasting partnerships with the healthcare providers we serve.
The STASKA Pharmaceutical Facility
STASKA Pharmaceuticals is equipped with state-of-the-art labs, equipment, and technology to ensure each product is developed with uncompromised quality. All processes and procedures are documented and executed with precision. Our proven technologies, high-quality products, and broad expertise consistently deliver you and your patients the best value. Schedule a consultation with STASKA to discuss your custom product today.
Facility Details
- 20,000 sq ft pharmaceutical compounding facility
- State-of-the-art sterile compounding operations
- Fully automated vial filling and processing line
- Advanced cleanroom compounding environment
- FDA-registered 503B outsourcing facility
- Current Good Manufacturing Practice (cGMP) compliant operations
- Comprehensive Quality Assurance and Quality Control programs
- In-house analytical and microbiology laboratories
Quality Assurance Department
At STASKA Pharmaceuticals, quality is not simply a department—it is the foundation of our organization. Every aspect of our operation is driven by a commitment to patient safety, product quality, and regulatory compliance.
Our Quality Management System (QMS) is designed to ensure that every product is compounded consistently, safely, and reliably. We believe that meeting regulatory and pharmacopeial requirements represents the minimum acceptable standard. Through continuous improvement, investment in technology, and a culture of accountability, we strive to exceed those standards whenever possible.
Consistency is achieved through disciplined processes, rigorous oversight, and a commitment to operational excellence. Our quality systems focus on risk management, process optimization, data-driven decision making, and continual improvement across all areas of the organization.
Our Quality Philosophy
Right First Time
- Prevent defects through robust process design and execution.
- Improve efficiency while maintaining the highest quality standards.
Risk-Based Compounding
- Identify, assess, and mitigate risks before they impact product quality.
- Utilize science-based decision making throughout the product lifecycle.
Culture of Transparency and Accountability
- Foster open communication, continuous learning, and quality ownership at every level of the organization.
- Promote a quality culture where patient safety remains the primary focus.
Our commitment extends beyond our own facility. We expect the same dedication to quality, compliance, and integrity from every supplier, contractor, and business partner involved in our supply chain.
Quality Control Department
Our Quality Control team provides independent oversight of compounding operations through comprehensive testing, monitoring, and release activities. Quality Control plays a critical role in ensuring that every batch meets established specifications before release.
STASKA maintains in-house analytical and microbiology laboratories capable of supporting chemical and microbiological testing programs. These capabilities enhance efficiency, strengthen oversight, and provide greater control over product quality.
Through strategic investments in facilities, technology, automation, and personnel, STASKA has built a quality infrastructure designed to meet today's regulatory expectations while preparing for the future of pharmaceutical compounding.
By combining advanced compounding technology, robust quality systems, and a patient-centered mission, STASKA Pharmaceuticals is committed to delivering high-quality sterile medications that healthcare providers can trust.